TOKYO, Apr 02 (Pulse News Wire) – Solasia Pharma K.K. (4597.T) revised certain details related to its additional investment in Isofol.
On April 01, 2026, the company had previously disclosed plans to invest further in Isofol but now provides updated figures: Pre-Correction Figures: - Post-investment number of Isofol shares held by Solasia: 8,333,328 - Post-investment stake in Isofol held by Solasia: 2.6% Corrected Figures: - Post-investment number of Isofol shares held by Solasia: 10,416,660 - Post-investment stake in Isofol held by Solasia: 3.25% The corrections highlight changes in Solasia's shareholding position post-investment. Investors should note these adjustments for accurate assessment of the company’s equity interests in Isofol.
Solasia emphasizes that forward-looking statements in this press release, such as performance forecasts, are based on currently available information and reasonable assumptions. Actual results could differ due to various factors, including economic conditions affecting the pharmaceutical sector, exchange rate fluctuations, and competitive dynamics.
Additionally, information about drugs or medical devices mentioned here is not intended for promotional or medical advice purposes.
🟢 Confidence: High AI-translated content.